We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$157M
AUM Growth
-$323M
Cap. Flow
-$292M
Cap. Flow %
-185.79%
Top 10 Hldgs %
79.11%
Holding
47
New
4
Increased
9
Reduced
4
Closed
16

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$12.9M
2
GS icon
Goldman Sachs
GS
+$5.99M
3
AAPL icon
Apple
AAPL
+$5.03M
4
WING icon
Wingstop
WING
+$3.28M
5
UNH icon
UnitedHealth
UNH
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 50.52%
2 Consumer Discretionary 15.87%
3 Communication Services 14.16%
4 Technology 3.54%
5 Financials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNOA icon
26
Sonoma Pharmaceuticals
SNOA
$5.6M
$668K 0.43%
561
STRR
27
DELISTED
Star Equity Holdings
STRR
$478K 0.3%
2,361
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
$447K 0.28%
17,865
ARLZ
29
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$432K 0.28%
319,664
-1,112,785
-78% -$1.61M
INSY
30
DELISTED
Insys Therapeutics, Inc.
INSY
$372K 0.24%
29,409
TLGT
31
DELISTED
Teligent, Inc
TLGT
$126K 0.08%
1,382
AAPL icon
32
CALL
Apple
AAPL
$5.02T
-800
Closed -$279M
AAPL icon
33
Apple
AAPL
$5.02T
-140,000
Closed -$5.03M
AMZN icon
34
CALL
Amazon
AMZN
$2.45T
-2,000
Closed -$481K
CSCO icon
35
Cisco
CSCO
$459B
-30,000
Closed -$1.01M
GS icon
36
Goldman Sachs
GS
$294B
-26,064
Closed -$5.99M
NFLX icon
37
Netflix
NFLX
$300B
-65,000
Closed -$961K
OTLK icon
38
Outlook Therapeutics
OTLK
$198M
-32
Closed -$14K
PLSE icon
39
Pulse Biosciences
PLSE
$2.46B
-21,954
Closed -$448K
SNGX icon
40
Soligenix
SNGX
$5.33M
-4
Closed -$3K
TSLA icon
41
Tesla
TSLA
$1.2T
-585,000
Closed -$12.9M
UNH icon
42
UnitedHealth
UNH
$386B
-20,000
Closed -$3.28M
WING icon
43
Wingstop
WING
$3.94B
-116,057
Closed -$3.28M
FLXN
44
DELISTED
Flexion Therapeutics, Inc.
FLXN
-10,000
Closed -$269K
ALDR
45
DELISTED
Alder Biopharmaceuticals
ALDR
-5,000
Closed -$104K
IPXL
46
DELISTED
Impax Laboratories, Inc.
IPXL
-30,000
Closed -$380K
CTIC
47
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-5,025
Closed -$21K

Similar funds

JW Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, JW Asset Management held 47 positions worth $157M, down 67% from $480M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

JW Asset Management withdrew a net $292M in Q2 2017, closing 16 positions and reducing 4 holdings. Its most notable exit was Tesla, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in State Street SPDR S&P Biotech ETF worth $2.31M.

  • JW Asset Management's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 30,000 shares worth $2.31M.
  • JW Asset Management added most to Antares Pharma, Inc. in Q2 2017, an estimated $1.03M increase.
  • JW Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $3.09M.
  • JW Asset Management fully exited Tesla in Q2 2017, selling an estimated $12.9M.
  • JW Asset Management's ten largest holdings make up 79% of its $157M portfolio in Q2 2017.
  • JW Asset Management opened 4 new positions and closed 16 in Q2 2017.
  • JW Asset Management's portfolio value fell 67% quarter-over-quarter to $157M.

Based on JW Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.